Page last updated: 2024-11-13

n-(3-n-(benzyloxycarbonyl)amino-1-carboxypropyl)leucyl-o-methyltyrosine n-methylamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-(3-N-(benzyloxycarbonyl)amino-1-carboxypropyl)leucyl-O-methyltyrosine N-methylamide: CI-1 and CI-2 are stereoisomers [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121231162
MeSH IDM0137085

Synonyms (5)

Synonym
sc 40827
collagenase inhibitor ci-2
n-(3-n-(benzyloxycarbonyl)amino-1-carboxypropyl)leucyl-o-methyltyrosine n-methylamide
boc-acp-leu-metyr-ma
l-tyrosinamide, n-(1-carboxy-3-((phenylacetyl)amino)propyl)-l-leucyl-n,o-dimethyl-, (s)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's4 (40.00)18.2507
2000's1 (10.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]